Conmed (CNMD)

Conmed Financial Statements


Conmed Financial Overview

Conmed's market cap is currently ―. The company's EPS TTM is $-3.966; its P/E ratio is -20.63; and it has a dividend yield of 0.95%. Conmed is scheduled to report earnings on October 26, 2022, and the estimated EPS forecast is $0.75. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 277.19M$ 242.33M$ 273.97M$ 248.83M$ 255.16M
Gross Profit$ 151.78M$ 135.99M$ 155.86M$ 142.31M$ 141.42M
EBIT$ -87.55M$ 22.44M$ 37.22M$ 25.58M$ 25.71M
EBITDA$ -70.23M$ 39.27M$ 54.69M$ 42.79M$ 43.49M
Net Income Common Stockholders$ -168.29M$ 14.97M$ 24.44M$ 14.95M$ 13.29M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 20.85M$ 24.86M$ 27.36M$ 31.51M$ 35.60M
Total Assets$ 2.07B$ 1.79B$ 1.77B$ 1.75B$ 1.76B
Total Debt$ 672.68M$ 715.57M$ 715.79M$ 720.06M$ 742.13M
Net Debt$ 651.83M$ 690.70M$ 688.43M$ 688.55M$ 706.53M
Total Liabilities$ 1.40B$ 996.18M$ 980.58M$ 998.41M$ 1.02B
Stockholders Equity$ 672.97M$ 683.14M$ 709.04M$ 725.57M$ 744.50M
Cash Flow
Free Cash Flow$ 13.03M$ -3.36M$ 30.60M$ 15.79M$ 31.29M
Operating Cash Flow$ 18.74M$ 328.00K$ 33.78M$ 21.36M$ 34.28M
Investing Cash Flow$ -148.27M$ -3.69M$ -3.19M$ -5.58M$ -2.99M
Financing Cash Flow$ 159.12M$ 7.49M$ -40.79M$ -29.79M$ -22.09M
Currency in USD

Conmed Earnings and Revenue History

Conmed Debt to Assets

Conmed Cash Flow

Conmed Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis